Bing Xiu

No 389 Xincun Road
Xincun, 200065, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Glofitamab in the sequential treatment of relapsed/refractory B-Cell lymphoma: a single-center real-world study.

Glofitamab in the sequential treatment of relapsed/refractory B-Cell lymphoma: a single-center real-world study.

Journal: Frontiers in oncology

Published: May 20, 2026

Predicting CAR-T outcomes in R/R DLBCL: a multicenter real-world study of a 5-index model.

Predicting CAR-T outcomes in R/R DLBCL: a multicenter real-world study of a 5-index model.

Journal: Frontiers in immunology

Published: April 23, 2026

TRIM37-Mediated Ubiquitination and Degradation of KMT2D Activates JAK2-STAT3 Signaling to Promote Diffuse Large B-Cell Lymphoma Progression.

TRIM37-Mediated Ubiquitination and Degradation of KMT2D Activates JAK2-STAT3 Signaling to Promote Diffuse Large B-Cell Lymphoma Progression.

Journal: Hematological oncology

Published: November 21, 2025

The predictive value of interleukin-2 receptor and prognostic nutritional index in patients with diffuse large B-cell lymphoma.

The predictive value of interleukin-2 receptor and prognostic nutritional index in patients with diffuse large B-cell lymphoma.

Journal: Frontiers in medicine

Published: November 02, 2025

MRI Features Associated with Plasma ctDNA Positivity in Central Nervous System Lymphoma.

MRI Features Associated with Plasma ctDNA Positivity in Central Nervous System Lymphoma.

Journal: Academic radiology

Published: September 17, 2025

Indolent T-cell lymphoma of the gastrointestinal tract coexisting with gastric signet-ring cell carcinoma: A case report and review of literature.

Indolent T-cell lymphoma of the gastrointestinal tract coexisting with gastric signet-ring cell carcinoma: A case report and review of literature.

Journal: World journal of gastroenterology

Published: August 19, 2025

Ubiquitin-specific protease 7-mediated stabilization of discoidin domain receptor 1 drives progression of TP53-Mutant cancers.

Ubiquitin-specific protease 7-mediated stabilization of discoidin domain receptor 1 drives progression of TP53-Mutant cancers.

Journal: The Journal of biological chemistry

Published: May 09, 2025

Germline mutations in B-cell non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH) and patient outcomes.

Germline mutations in B-cell non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH) and patient outcomes.

Journal: Seminars in oncology

Published: April 15, 2025

Timosaponin AIII enhances CAR-T cell potency and prevents relapse through impairing CAR-Tregs.

Timosaponin AIII enhances CAR-T cell potency and prevents relapse through impairing CAR-Tregs.

Journal: Nature communications

Published: January 24, 2025

CAR T-cell therapy combined with autologous hematopoietic cell transplantation in patients with refractory/relapsed Burkitt Lymphoma.

CAR T-cell therapy combined with autologous hematopoietic cell transplantation in patients with refractory/relapsed Burkitt Lymphoma.

Journal: Current research in translational medicine

Published: October 17, 2024

Single nucleotide polymorphism and promoter methylation analysis of protein tyrosine phosphatase 1B in patients with myeloproliferative neoplasms.

Single nucleotide polymorphism and promoter methylation analysis of protein tyrosine phosphatase 1B in patients with myeloproliferative neoplasms.

Journal: Translational cancer research

Published: August 01, 2024

CD19 CAR-T treatment shows limited efficacy in r/r DLBCL with double expression and TP53 alterations.

CD19 CAR-T treatment shows limited efficacy in r/r DLBCL with double expression and TP53 alterations.

Journal: Cytotherapy

Published: April 15, 2024

Showing 1-12 of 34

Last Updated: 09/26/2026